0001731122-24-000918.txt : 20240606
0001731122-24-000918.hdr.sgml : 20240606
20240606153352
ACCESSION NUMBER: 0001731122-24-000918
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240102
FILED AS OF DATE: 20240606
DATE AS OF CHANGE: 20240606
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pfisterer Thomas
CENTRAL INDEX KEY: 0001824238
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39071
FILM NUMBER: 241024816
MAIL ADDRESS:
STREET 1: NEUGASSE 22
CITY: ZUG
STATE: V8
ZIP: 6300
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ADC Therapeutics SA
CENTRAL INDEX KEY: 0001771910
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: BIOPOLE
STREET 2: ROUTE DE LA CORNICHE 3B
CITY: EPALINGES
STATE: V8
ZIP: 1066
BUSINESS PHONE: 41 21 653 02 00
MAIL ADDRESS:
STREET 1: BIOPOLE
STREET 2: ROUTE DE LA CORNICHE 3B
CITY: EPALINGES
STATE: V8
ZIP: 1066
3
1
ownership.xml
X0206
3
2024-01-02
0
0001771910
ADC Therapeutics SA
ADCT
0001824238
Pfisterer Thomas
NEUGASSE 22
ZUG
V8
6300
SWITZERLAND
1
0
0
0
Common shares
607193
D
Thomas Pfisterer holds a portion of the shares directly and the other portion indirectly via HPWH TH AG ("HPWH") and HPWH MH AG ("MH"). The principal business of HPWH is holding investment rights in, directly or indirectly, ADC Therapeutics. HP WILD Holding AG ("HPW Holding") is an intermediary holding company. Thomas Pfisterer is a board member of HPWH. By reason of a stockholders' agreement by and among Mr. Pfisterer and HPW Holding and their joint indirect minority equity interest in HPWH via their joint ownership of MH, which owns a 12.5% interest in HPWH, Mr. Pfisterer may be deemed to have shared voting and investment power with respect to such shares held of record by HPWH. However, Mr. Pfisterer disclaims beneficial ownership of all common shares held of record by HPWH other than the shares indirectly represented by his 41.7% interest in MH.
/s/ Thomas Pfisterer
2024-05-14